The combination of poor FGFR1-FGF1 signaling with obesity-induced insulin resistance results in worse lipolytic regulation in the adipose tissue of Ndst1 AKO mice and leads to the observed increased hepatic steatosis [32,45] and hyperglycemia. Here, FGFR1 is linked to fatty liver disease.